VHL mutations are associated with increased expression of VHL and ubiquitin in clear cell renal cell carcinoma.

被引：0
|
作者：
Hughson, M [1 ]
He, Z [1 ]
Liu, S [1 ]
Shingleton, WB [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
641
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [21] VHL mutations of renal cell carcinoma from hemodialysis patients
    Hashimoto, Y
    Ito, F
    Onitsuka, S
    Okuda, H
    Kondo, T
    Nakazawo, H
    Toma, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 171 - 171
  • [22] Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
    Zhang, Jin
    Yan, Aiting
    Cao, Wei
    Shi, Honglei
    Cao, Kai
    Liu, Xiaowu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [23] Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
    Jin Zhang
    Aiting Yan
    Wei Cao
    Honglei Shi
    Kai Cao
    Xiaowu Liu
    Cancer Cell International, 20
  • [24] VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
    Schraml, P
    Struckmann, K
    Hatz, F
    Sonnet, S
    Kully, C
    Gasser, T
    Sauter, G
    Mihatsch, MJ
    Moch, H
    JOURNAL OF PATHOLOGY, 2002, 196 (02): : 186 - 193
  • [25] Kidneys of VHL patients reveal the origin of renal clear cell carcinoma
    Mubarak, Mayyan
    Sommaruga, Samuel
    Voigt, David
    Xu, Xiacao
    Kim, Steve
    Song, Ailin
    Vortmeyer, Alexander O.
    CANCER RESEARCH, 2016, 76
  • [26] Cytosine 5-hydroxymethylation regulates VHL gene expression in renal clear cell carcinoma
    Ma, En-Guang
    Bai, Yu-Feng
    Cao, Wei
    Cao, Yan
    Huang, Yong-Gang
    Cheng, Huan-Chen
    An, Rui-Hua
    ONCOTARGET, 2017, 8 (38) : 63780 - 63787
  • [27] Insights into epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma
    Ricketts, Christopher J.
    Linehan, W. Marston
    CANCER DISCOVERY, 2017, 7 (11) : 1221 - 1223
  • [28] VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
    Yao, Xiaosai
    Tan, Jing
    Lim, Kevin Junliang
    Koh, Joanna
    Ooi, Wen Fong
    Li, Zhimei
    Huang, Dachuan
    Xing, Manjie
    Chan, Yang Sun
    Qu, James Zhengzhong
    Tay, Su Ting
    Wijaya, Giovani
    Lam, Yue Ning
    Hong, Jing Han
    Lee-Lim, Ai Ping
    Guan, Peiyong
    Ng, Michelle Shu Wen
    He, Cassandra Zhengxuan
    Lin, Joyce Suling
    Nandi, Tannistha
    Qamra, Aditi
    Xu, Chang
    Myint, Swe Swe
    Davies, James O. J.
    Goh, Jian Yuan
    Loh, Gary
    Tan, Bryan C.
    Rozen, Steven G.
    Yu, Qiang
    Tan, Iain Bee Huat
    Cheng, Christopher Wai Sam
    Li, Shang
    Chang, Kenneth Tou En
    Tan, Puay Hoon
    Silver, David Lawrence
    Lezhava, Alexander
    Steger, Gertrud
    Hughes, Jim R.
    Teh, Bin Tean
    Tan, Patrick
    CANCER DISCOVERY, 2017, 7 (11) : 1284 - 1305
  • [29] A detailed analysis of von Hippel Lindau (VHL) mutations in sporadic clear cell renal carcinoma (ccRCC), VHL syndrome, and Chuvash polycythaemia.
    Gossage, L.
    Cartwright, E.
    Eisen, T.
    Bycroft, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Expression of VHL and SRC in metastatic renal cell carcinoma (mRCC).
    Luo, Jia
    Podolak, Jennifer
    Degnin, Catherine
    Chen, Yiyi
    Robinson, Kyle William
    Pukay, Marina
    Schilling, Amy
    Poage, Cara
    Thomas, George V.
    Ryan, Christopher W.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345